Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

L Malcovati, E Hellström-Lindberg… - Blood, The Journal …, 2013 - ashpublications.org
Within the myelodysplastic syndrome (MDS) work package of the European LeukemiaNet,
an Expert Panel was selected according to the framework elements of the National Institutes …

Ineffective erythropoiesis and regulation of iron status in iron loading anaemias

C Camaschella, A Nai - British journal of haematology, 2016 - Wiley Online Library
The definition 'iron loading anaemias' encompasses a group of inherited and acquired
anaemias characterized by ineffective erythropoiesis, low hepcidin levels, excessive iron …

How I treat transfusional iron overload

AV Hoffbrand, A Taher… - Blood, The Journal of the …, 2012 - ashpublications.org
Patients with β-thalassemia major (TM) and other refractory anemias requiring regular blood
transfusions accumulate iron that damages the liver, endocrine system, and most importantly …

Physiology and pathophysiology of iron in hemoglobin-associated diseases

TD Coates - Free Radical Biology and Medicine, 2014 - Elsevier
Iron overload and iron toxicity, whether because of increased absorption or iron loading from
repeated transfusions, can be major causes of morbidity and mortality in a number of chronic …

The clinical significance of iron overload and iron metabolism in myelodysplastic syndrome and acute myeloid leukemia

S Weber, A Parmon, N Kurrle, F Schnütgen… - Frontiers in …, 2021 - frontiersin.org
Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) are clonal
hematopoietic stem cell diseases leading to an insufficient formation of functional blood …

The pathophysiology of transfusional iron overload

JB Porter, M Garbowski - Hematology/oncology clinics, 2014 - hemonc.theclinics.com
Iron homeostatic mechanisms are key to the pathophysiology of transfusional iron overload
(TIO). In humans, these mechanisms are best adapted to increasing iron acquisition in …

Iron overload in myelodysplastic syndromes (MDS)

N Gattermann - International journal of hematology, 2018 - Springer
Iron overload (IOL) starts to develop in MDS patients before they become transfusion-
dependent because ineffective erythropoiesis suppresses hepcidin production in the liver …

Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome

N Shenoy, N Vallumsetla… - Blood, The Journal …, 2014 - ashpublications.org
Myelodysplastic syndromes (MDSs) are a group of heterogeneous clonal bone marrow
disorders characterized by ineffective hematopoiesis, peripheral blood cytopenias, and …

[HTML][HTML] Myelodysplastic syndromes: diagnosis, prognosis, and treatment

U Germing, G Kobbe, R Haas… - Deutsches Ärzteblatt …, 2013 - ncbi.nlm.nih.gov
Background Myelodysplastic syndromes (MDS) are malignant stem-cell diseases that are
usually diagnosed in elderly patients who present with anemia or, less commonly, bi-or …

Sideroblastic anemia: diagnosis and management

SS Bottomley, MD Fleming - Hematology/Oncology Clinics, 2014 - hemonc.theclinics.com
When first defined 50 years ago, sideroblastic anemia (SA) was already recognized to occur
in heterogeneous settings, including as familial or acquired disease. 1 The spectrum of SA …